Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
Source
US National Institutes of HealthThese guidelines spell out why strict adherence to antiretroviral therapy (ART) is key to sustained HIV suppression, reduced risk of drug resistance, improved overall health, quality of life, and survival, as well as decreased risk of HIV transmission.
They provide updated guidance on assessing and monitoring adherence and outlines strategies to help patients maintain high levels of adherence, including utilizing approaches of interpersonal communication and counseling. The guidelines include a table explaining strategies to improve adherence to antiretroviral therapy and retention in care.
- Joint WHO/ILO Guidelines on Post-Exposure Prophylaxis (PEP) to Prevent HIV Infection
- Guidance for the Prevention of Sexually Transmitted HIV Infections
- Treatment 2015
- Optimizing Entry Into and Retention in HIV Care and ART Adherence for PLWHA
- Setting Up A Hotline
- WHO Daily Situation Reports
- Antiretroviral Therapy for HIV Infection in Infants and Children: Recommendations for a Public Health Approach
- Driving the HIV response: Community Guide to the WHO 2013 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
- Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
- Integrating Family Planning and Antiretroviral Therapy: A Client-oriented Service Model
Last Updated
November 30, 2020
